<p><b>A</b>, Data from Sun Brain [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0081803#B19" target="_blank">19</a>], and TCGA Brain (<a href="https://tcga-data.nci.nih.gov/tcga/tcgahome2.jsp" target="_blank"><u>https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp</u></a>) comparing microarray-based STK17A expression from clinical nonmalignant brain specimens (Norm. Brain) and clinical GBM indicating high expression of STK17A in GBM. <b>B</b>, Real-time PCR analysis of STK17A expression in GBM cell lines compared to expression in other cancer types and normal brain. Expression is normalized to GAPDH. Bars are the average of triplicate or duplicate biological replicates except for normal brain RNA which is the average of technical duplicates. Error bars are SD. All cell lines are human. Non-GBM cell lines are as follows: NT2 (NT2/D1), embryonal carcinoma; U2OS, osteosarcoma; H23, A549, and Hop62, lung adenocarcinomas; MCF7, breast cancer. <b>C</b>, Real-time PCR analysis of STK17A expression in normal brain mRNA and four clinical GBM samples from Dartmouth Hitchcock Medical Center. Expression is normalized to GAPDH. The bars represent the averages of technical duplicate determinations. </p
